Thomas Catinazzo insider trades

Open-market stock purchases and sales by Thomas Catinazzo, Chief Financial Officer at Relay Therapeutics, Inc, from SEC Form 4 filings since Dec 11, 2020.

Recent trades

DateStockTradeValue
Jun 22, 2026RLAY Relay Therapeutics, IncSold$301K
Jun 22, 2026RLAY Relay Therapeutics, IncSold$956K
Jun 22, 2026RLAY Relay Therapeutics, IncSold$1M
Jun 22, 2026RLAY Relay Therapeutics, IncSold$875K
Jun 22, 2026RLAY Relay Therapeutics, IncBought (not open market)—
Jun 22, 2026RLAY Relay Therapeutics, IncBought (not open market)—
Jun 22, 2026RLAY Relay Therapeutics, IncBought (not open market)—
May 14, 2026RLAY Relay Therapeutics, IncSold$228K
Apr 28, 2026RLAY Relay Therapeutics, IncSold$14.4K
Apr 9, 2026RLAY Relay Therapeutics, IncSold$27K
Apr 9, 2026RLAY Relay Therapeutics, IncBought (not open market)—
Apr 7, 2026RLAY Relay Therapeutics, IncSold$230K
Mar 9, 2026RLAY Relay Therapeutics, IncSold$178K
Jan 28, 2026RLAY Relay Therapeutics, IncSold$14.3K
Jan 27, 2026RLAY Relay Therapeutics, IncSold$105K
Jan 13, 2026RLAY Relay Therapeutics, IncBought (not open market)—
Oct 28, 2025RLAY Relay Therapeutics, IncSold$158K

Companies traded

  • RLAY Relay Therapeutics, Inc: 64 sales, last Jun 22, 2026

Get free alerts when Thomas Catinazzo files a new trade →